These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22870868)

  • 1. Mouse precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury.
    Hadi M; Chen Y; Starokozhko V; Merema MT; Groothuis GM
    Chem Res Toxicol; 2012 Sep; 25(9):1938-47. PubMed ID: 22870868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury.
    Hadi M; Westra IM; Starokozhko V; Dragovic S; Merema MT; Groothuis GM
    Chem Res Toxicol; 2013 May; 26(5):710-20. PubMed ID: 23565644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFα-mediated hepatotoxicity.
    Fredriksson L; Wink S; Herpers B; Benedetti G; Hadi M; de Bont H; Groothuis G; Luijten M; Danen E; de Graauw M; Meerman J; van de Water B
    Toxicol Sci; 2014 Jul; 140(1):144-59. PubMed ID: 24752500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profiling in incubation medium of mouse, rat and human precision-cut liver slices for biomarker detection regarding acute drug-induced liver injury.
    van Swelm RP; Hadi M; Laarakkers CM; Masereeuw R; Groothuis GM; Russel FG
    J Appl Toxicol; 2014 Sep; 34(9):993-1001. PubMed ID: 24038040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editor's Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI.
    Mak A; Kato R; Weston K; Hayes A; Uetrecht J
    Toxicol Sci; 2018 Feb; 161(2):412-420. PubMed ID: 29087505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a human in vitro hepatocyte-NPC co-culture model for the prediction of idiosyncratic drug-induced liver injury: A pilot study.
    Granitzny A; Knebel J; Müller M; Braun A; Steinberg P; Dasenbrock C; Hansen T
    Toxicol Rep; 2017; 4():89-103. PubMed ID: 28959630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept Study.
    Maiuri AR; Wassink B; Turkus JD; Breier AB; Lansdell T; Kaur G; Hession SL; Ganey PE; Roth RA
    J Pharmacol Exp Ther; 2017 Sep; 362(3):459-473. PubMed ID: 28687704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
    Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
    J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice.
    Tiegs G; Barsig J; Matiba B; Uhlig S; Wendel A
    J Clin Invest; 1994 Jun; 93(6):2616-22. PubMed ID: 8201000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha.
    Görgen I; Hartung T; Leist M; Niehörster M; Tiegs G; Uhlig S; Weitzel F; Wendel A
    J Immunol; 1992 Aug; 149(3):918-24. PubMed ID: 1378868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of quantitative systems pharmacology modeling in the prediction and explanation of idiosyncratic drug-induced liver injury.
    Woodhead JL; Watkins PB; Howell BA; Siler SQ; Shoda LKM
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):40-45. PubMed ID: 28129975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute exposure to cadmium induces prolonged neutrophilia along with delayed induction of granulocyte colony-stimulating factor in the livers of mice.
    Horiguchi H; Oguma E
    Arch Toxicol; 2016 Dec; 90(12):3005-3015. PubMed ID: 26790433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities.
    Ong MM; Latchoumycandane C; Boelsterli UA
    Toxicol Sci; 2007 May; 97(1):205-13. PubMed ID: 17150972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric mice with a humanized liver as an animal model of troglitazone-induced liver injury.
    Kakuni M; Morita M; Matsuo K; Katoh Y; Nakajima M; Tateno C; Yokoi T
    Toxicol Lett; 2012 Oct; 214(1):9-18. PubMed ID: 22902350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic Synergy Between Cytokines and NSAIDs Associated With Idiosyncratic Hepatotoxicity Is Driven by Mitogen-Activated Protein Kinases.
    Maiuri AR; Breier AB; Gora LF; Parkins RV; Ganey PE; Roth RA
    Toxicol Sci; 2015 Aug; 146(2):265-80. PubMed ID: 25953702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury.
    Benesic A; Leitl A; Gerbes AL
    Gut; 2016 Sep; 65(9):1555-63. PubMed ID: 26045135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of granulocyte-macrophage colony-stimulating factor and lipopolysaccharide-induced signal transduction pathways that synergize to stimulate HIV type 1 production by monocytes from HIV type 1 transgenic mice.
    Osiecki K; Xie L; Zheng JH; Squires R; Pettoello-Mantovani M; Goldstein H
    AIDS Res Hum Retroviruses; 2005 Feb; 21(2):125-39. PubMed ID: 15725751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset.
    Metushi IG; Cai P; Dervovic D; Liu F; Lobach A; Nakagawa T; Uetrecht J
    J Immunotoxicol; 2015; 12(3):247-60. PubMed ID: 25046026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of CCL2/CCR2 macrophage recruitment in amodiaquine-induced liver injury.
    Mak A; Uetrecht J
    J Immunotoxicol; 2019 Dec; 16(1):28-33. PubMed ID: 30663942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.